Diabetes Online-Kongress 2021
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. Mark Hauser
Novo Nordisk Pharma GmbH
Germany
Vortrag
Oral Semaglutide vs. Sitagliptin: Efficacy by Baseline HbA1c and Background OAD in PIONEER 3
Speaker
Datum: 14.05.2021 , Zeit: 08:30
|
Thema: Posterkurzvortrag
Details
Vortrag
Efficacy of oral semaglutide according to diabetes duration: An exploratory subgroup analysis of the PIONEER trial programme
Speaker
Datum: 14.05.2021 , Zeit: 09:12
|
Thema: Posterkurzvortrag
Details
zur online Kongressplattform